Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase NA 4Phase 2 3Phase 4 2Phase 1 2

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pain 6Neoplasms 3Neoplasm Metastasis 2Cancer Pain 2Breast Neoplasms 2Wounds and Injuries 1Pleural Effusion, Malignant 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Leiomyoma 1Ileus 1Head and Neck Neoplasms 1Agnosia 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Morphine × Clear all
NCT03564548 2021-07-28

REBORN

Tetra Bio-Pharma

Phase 2 Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

NCT00446069 2016-08-29

A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

Egalet Ltd

Phase 2 Completed
36 enrolled

Neoplasms, Pain

NCT00573937 2016-02-19

Methadone Versus Morphine for Cancer-Related Pain

Mayo Clinic

Phase 2 Terminated
1 enrolled 2 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡